Oops, looks like you need to register to access this feature.
Select “Keep Exploring” to look around Scholars in Medicine. You have full access to all videos and podcasts for a limited time. Registration is provided at no cost exclusively for healthcare providers.
Sign Up or Log In

4-n-butylresorcinol

Brand and Other Names: rucinol
Mechanism of Action:
Indications:
Route:
Dose:
Adverse Reactions:
Contraindication:
Warnings and Precautions:
Description:

Not FDA approved

GOOGLE OVERVIEW

4-n-butylresorcinol, also known as rucinol, is a skin-lightening agent used in cosmetics to address hyperpigmentation. It works by inhibiting the enzyme tyrosinase, which plays a key role in melanin production. This inhibition can help reduce the appearance of dark spots, uneven skin tone, and other hyperpigmentation concerns. 
 
Here's a more detailed explanation:
  • Tyrosinase Inhibition:
    4-n-butylresorcinol is a potent tyrosinase inhibitor, meaning it can slow down or block the activity of this enzyme. 
     
  • Melanin Production:
    Tyrosinase is crucial for melanin synthesis, the process that gives skin its color. By inhibiting tyrosinase, 4-n-butylresorcinol can help reduce the amount of melanin produced, leading to a lightening effect on the skin. 
     
Hyperpigmentation Reduction:
Hyperpigmentation, including dark spots, melasma, and uneven skin tone, is often caused by excessive melanin production. 4-n-butylresorcinol can help fade these discolorations by reducing melanin production. 
 
Skincare Applications:
4-n-butylresorcinol is used in various skincare products like creams, serums, and lotions designed to brighten the skin and address hyperpigmentation. 
 
Effectiveness:
Studies have shown that 4-n-butylresorcinol can be more effective than other commonly used skin-lightening ingredients like hydroquinone, arbutin, and kojic acid,according to The Formulator Shop. 
 
Safety:
While generally considered safe, some individuals may experience mild skin irritation.The Environmental Working Group (EWG) Skin Deep database indicates that products with 4-butylresorcinol have low scores for common concerns like cancer, allergies, and reproductive toxicity. 
 
 

 

See package insert for full prescribing information.